Solution structure of the capsid protein from the human T-cell leukemia virus type-1

Journal of Molecular Biology

Volumn 291, Issue 2, 1999, Pages 491-505

  Khorasanizadeh, Sepideh ^a   Campos Olivas, Ramón ^a   Summers, Michael F ^a  

^a UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

Author keywords

Capsid protein; Heteronuclear NMR spectroscopy; HTLV I; Retrovirus; Three dimensional structure

Indexed keywords

CAPSID PROTEIN; CYSTEINE;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; DIMERIZATION; DISULFIDE BOND; EQUINE INFECTIOUS ANEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OXIDATION; PRIORITY JOURNAL; PROTEIN CONFORMATION;

EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1; MIRIDAE; UNIDENTIFIED RETROVIRUS;

EID: 0032781006     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.2986     Document Type: Article

References (76)

1. Bacon D. J., Anderson W. F. A fast algorithm for rendering space-filling molecule pictures. J. Mol. Graph. 6:1988;219-220.
2. Barklis E., McDermott J., Wilkens S., Schabtach E., Schmid M. F., Fuller S., Karanjia S., Love Z., Jones R., Rui Y., Zhao X., Thompson D. Structural analysis of membrane-bound retrovirus capsid proteins. EMBO J. 16:1997;1199-1213.
3. Barklis E., McDermott J., Wilkens S., Fuller S., Thompson D. Organization of HIV-1 capsid proteins on a lipid monolayer. J. Biol. Chem. 273:1998;7177-7180.
4. Berthet-Colominas C., Monaco S., Novelli A., Sibai G., Mallet F., Cusack S. Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab. EMBO J. 18:1999;1124-1136.
5. Braaten D., Franke E. K., Luban J. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type-1 before the initiation of reverse transcription. J. Gen. Virol. 1996;3551-3560.
6. Brooks D. G., Watts K. K., Soneson P., Hensley. Determining confidence intervals for parameters derived from analysis of equilibrium analytical ultracentrifugation. Methods Enzymol. 240:1994;459-478.
7. Campbell S., Vogt V. M. In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles. J. Virol. 71:1997;4425-4435.
8. Campos-Olivas R., Summers M. F. Backbone dynamics of the N-terminal domain of the HIV-1 capsid protein and comparison with the G94D mutant conferring cyclosporin resistance/dependence. Biochemistry. in the press:1999.
9. Chazal N., Carrière C., Gay B., Boulanger P. Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells. J. Virol. 68:1994;111-122.
10. Christiansen G., Landers T., Griffith J., Berg P. Characterization of components released by alkali disruption of simian virus 40. J. Virol. 21:1977;1079-1084.
11. Clore G. M., Gronenborn A. M. Structures of larger proteins in solution: Three- and four-dimensional heteronuclear NMR spectroscopy. Science. 252:1991;1390-1399.
12. Delaglio F., Grzesiek S., Vuister G. W., Zhu G., Pfeifer J., Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR. 6:1995;277-293.
13. Dorfman A. T., Bukovsky A., Ohagen A. S., Hoglund H., Gottlinger G. Functional domains of the capsid protein of human immunodeficiency virus type 1. J. Virol. 68:1994;8180-8187.
14. Ellman G. L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82:1959;70-77.
15. Ferreira O. C. Jr, Planelles V., Rosenblatt J. D. Human T-cell leukemia viruses: epidemoilogy, biology, and pathogenesis. Blood Rev. 11:1997;91-104.
16. Franke E. K., Yuan H. E. H., Bossolt K. L., Goff S. P., Luban J. Specificity and sequence requirements for interactions between various retroviral Gag proteins. J. Virol. 68:1994a;5300-5305.
17. Franke K. E., En Hui Yuan H., Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature. 24:1994b;359-362.
18. Frankel A. D., Young J. A. T. HIV-1: fifteen proteins and an RNA. Annu. Rev. Biochem. 67:1998;1-25.
19. Gamble T. R., Vajdos F., Yoo S., Worthylake D. K., Houseweart S. M., Sundquist W. I., Hill C. P. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell. 87:1996;1285-1294.
20. Gamble T. R., Yoo S., Vajdos F. F., von Schwedler U. K., Korthylake D. K., Wang H., McCutcheon J. P., Sundquist W. I., Hill C. P. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science. 278:1997;849-853.
21. Ganser B. K., Li S., Klishko V. Y., Finch J. T., Sundquist W. I. Assembly and analysis of conical models for the HIV-1 core. Science. 283:1999;80-83.
22. Gill S. C., von Hippel P. H. Calculation of protein extinction coefficients from amino acid sequence. Anal. Biochem. 189:1989;319-326.
23. Gitti R. K., Lee B. M., Walker J., Summers M. F., Yoo S., Sundquist W. I. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science. 273:1996;231-235.
24. Göttlinger H. G., Sodroski J. G., Haseltine W. A. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA. 86:1989;5781-5785.
25. Green P. L., Chen I. S. Regulation of human T-cell leukemia virus expression. FASEB J. 4:1990;169-175.
26. Green P. L., Chen I. S. Molecular features of the human T-cell leukemia virus. Mechanisms of transformation and leukemogenesis. Levy J. A. The Retroviridae. 1994;277-311 Plenum Press, New York.
27. 15N-enriched proteins. Applications to HIV-1 Nef. J. Am. Chem. Soc. 117:1995;9594-9595.
28. Güntert P., Mumenthaler C., Wüthrich K. Torsion angle dynamics for protein structure calculations with a new program, DYANA. J. Mol. Biol. 273:1997;283-298.
29. Harrison S. C., Skehel J. J., Wiley D. C. Virus structure. Fields B. N., Knipe D. M., Howley P. M., Al E. Virology. 1996;59-99 Lippincott-Raven, New York.
30. Hjelle B. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet. 339:1992;645-646.
31. Hockley D. J., Nermut M. V., Grief C., Jowett J. B. M., Jones I. M. Comparative morphology of Gag protein structures produced by mutants of the gag gene of human immunodeficiency virus type 1. J. Gen. Virol. 75:1994;2985-2997.
32. Hollsberg P., Hafler D. A. Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection. New Engl. J. Med. 328:1993;1173-1182.
33. Hong S. S., Boulanger P. Assembly-defective point mutants of the human immunodeficiency virus type 1 Gag precursor phenotypically expressed in recombinant baculovirus-infected cells. J. Virol. 67:1993;2787-2798.
34. Jin Z., Jin L., Peterson D. L., Lawson C. L. Model for lentivirus capsid core assembly based on crystal dimers of EIAV p26. J. Mol. Biol. 286:1999;83-93.
35. Johnson B. A., Blevins R. A. NMRview: a computer program for the visualization and analysis for NMR data. J. Biomol. NMR. 4:1994;603-614.
36. Jowett J., Hockley D., Nermut M. V., Jones I. M. Distinct signals in human immunodeficiency virus type 1 Pr55 necessary for RNA binding and particle formation. J. Gen. Virol. 73:1992;3079-3086.
37. Khabbaz R. F., Fukuda K., Kaplan J. E. Guidelines for counseling human T-lymphotropic virus type I (HTLV-I) and HTLV type II-infected persons. Transfusion. 33:1993;694.
38. 15N chemical shift assignment and secondary structure of the HTLV-I capsid protein. J. Biomol. NMR. 14:1999;199-200.
39. Kraulis P. J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallog. 24:1991;946-950.
40. Laskowski R. A., Rullmann J. A. C., MacArthur M. W., Kaptein R., Thornton J. M. AQUA and Procheck NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR. 8:1996;477-486.
41. Luban J. Absconding with the chaperone: essential cyclophilin-Gag interaction in HIV-1 virions. Cell. 87:1996;1557-1559.
42. Luban J., Bossolt K. L., Franke E. K., Kalpana G. V., Goff S. P. Human immunodeficiency virus type 1 gag protein binds to cyclophilins A and B. Cell. 73:1993;1067-1078.
43. Luban J., Franke E. K., Yuan H. E. HIV-1 uses host-cell proteins to form fully infectious virions. Nature. 7:1994;37-42.
44. α chemical shifts in protein structure determination. J. Magn. Reson. ser. B. 109:1995;229-233.
45. McDermott J., Farrell L., Ross R., Barklis E. Structural analysis of human immunodeficiency virus type 1 Gag protein interactions, using cysteine-specific reagents. J. Virol. 70:1996;5106-5114.
46. Momany C., Kovari L. C., Prongay A. J., Keller W., Gitti R. K., Lee B. M., Gorbalenya A. E., Tong L., McClure J., Ehrlich L. S., Summers M. F., Carter C., Rossmann M. G. Crystal structure of dimeric HIV-1 capsid protein. Nature Struct. Biol. 9:1996;763-770.
47. Mueller N. The epidemiology of HTLV-I infection. Cancer Causes Control. 2:1991;37-52.
48. Nermut M. V., Thomas D. Fullerene-like organization of HIV gag-protein shell in virus-like particles produced by recombinant baculovirus. Virology. 198:1994;288-296.
49. Nermut M. V., Grief C., Hashmi S., Hockley D. J. Further evidence of icosahedral symmetry in human and simian immunodeficiency virus. AIDS Res. Hum. Retroviruses. 9:1993;929-938.
50. Osame M., Matsumoto M., Usuku K., Izumo S., Ijichi N., Amitani H., Tara M., Igata A. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemia-like cells. Ann. Neurol. 21:1987;117-122.
51. Reicin A. S., Paik S., Berkowitz R. D., Luban J., Lowy I., Goff S. P. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity. J. Virol. 69:1995;642-650.
52. Riddles P. W., Blakeley R. L., Zerner B. Reassesment of Ellman's reagent. Methods Enzymol. 91:1983;49-60.
53. Rosé S., Hensley P., O'Shannessy D. J., Culp J., Debouck C., Chaiken I. Characterization of HIV-1 p24 self-association using analytical affinity chromatography. Proteins: Struct. Funct. Genet. 13:1992;112-119.
54. Rossmann M. G. Viral cell recognition and entry. Protein Sci. 3:1994;1712-1725.
55. Sapp M., Fligge C., Petzak I., Harris R., Streeck R. E. Papillomavirus assembly requires trimerization of the major capsid protein by disulfides between two highly conserved cysteines. J. Virol. 72:1998;6186-6189.
56. Spearman P., Wang J.-J., Vander Heyden N., Ratner L. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J. Virol. 68:1994;3232-3242.
57. Stewart S. A., Poon B., Chen I. S. Y. Mechanism of HTLV-I leukemogenesis. Minson A., Neil S., McCree M. Viruses and Cancer. 1994;167-192 Cambridge University Press, Cambridge.
58. Studier F. W., Rosenberg A. H., Dunn J. J., Dubendorff J. W. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185:1990;60-89.
59. Thali M., Bukovsky A., Kondo E., Rosenwirth B., Walsh C. T., Sodroski J., Gottlinger H. G. Functional association of cyclophilin A with HIV-1 virions. Nature. 372:1994;363-365.
60. Turner B. G., Summers M. F. Structural biology of HIV. J. Mol. Biol. 285:1999;1-32.
61. Uchiyama T., Yodoi J., Sagawa K., Takatsuki K., Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 50:1977;481-492.
62. Vogt P. K. Historical introduction to the general properties of retroviruses. Coffin J. M., Hughes S. H., Varmus H. E. Retroviruses. 1997a;1-25 Cold Spring Harbor Laboratory Press, Plainview.
63. Vogt V. M. Retroviral virions and genomes. Coffin J. M., Hughes S. H., Varmus H. E. Retroviruses. 1997b;27-69 Cold Spring Harbor Laboratory Press, Plainview.
64. Von Poblotzki A., Wagner R., Niedrig M., Wanner G., Wolf H., Modrow S. Identification of a region in the Pr55gag polyprotein essential for HIV-1 particle formation. Virology. 193:1993;981-985.
65. Von Schwedler U. K., Stemmler T. L., Klishko V. Y., Li S., Albertine K. H., Davis D. R., Sundquist W. I. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J. 17:1998;1555-1568.
66. Walter G., Deppert W. Intermolecular disulfide bonds: an important structural feature of the polyomavirus capsid. Cold Spring Harbor Symp. Quant. Biol. 39:1974;255-257.
67. Wang C.-T., Barklis E. Assembly, processing, and infectivity of human immunodeficiency virus type 1 Gag mutants. J. Virol. 67:1993;4264-4273.
68. Williams A. E., Fang C. T., Slamon D. J., Poiesz B. J., Sandler S. G., Darr W. F. D., Shulman G., McGowan E. I., Douglas D. K., Bowman R. J. Seroprevalence and epidemiological correlates of HTLV-I infection in U. S. blood donors. Science. 240:1988;643-646.
69. 13C chemical-shift data. J. Biomol. NMR. 4:1994;171-180.
70. 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects. J. Biomol. NMR. 5:1995;67-81.
71. Worthylake D. K., Wang H., Yoo S., Sundquist W. I., Hill C. P. Structures of the HIV-1 capsid protein dimerization domain at 2.6 Å resolution. Acta Crystallog. sect. D. 55:1999;85-92.
72. Wüthrich K. NMR of Proteins and Nucleic Acids. 1986;John Wiley & Sons, New York.
73. Yodoi J., Takatsuki K., Masuda T. Letter: two cases of T-cell chronic lymphocytic leukemia in Japan. New Engl. J. Med. 290:1974;572-573.
74. Yoo S., Myszka D. G., Yeh C., McMurray M., Hill C. P., Sundquist W. I. Molecular recognition in the HIV-1 capsid/cyclophilin A complex. J. Mol. Biol. 269:1997;780-795.
75. Yoshida M., Miyoshi I., Hinuma Y. Isolation and characterization of retrovirus (ATLV) from cell lines of human adult T-cell leukemia and its implication in the diseases. Proc. Natl Acad. Sci. USA. 79:1982;2031-2035.
76. Zhao T. M., Robinson M. A., Bowers F. S., Kindt T. J. Characterization of an infectious molecular clone of human T-cell leukemia virus type I. J. Virol. 69:1995;2024-2030.